Shares of Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $15.03 and traded as high as $16.31. Orthofix Medical shares last traded at $16.18, with a volume of 174,052 shares trading hands.
Orthofix Medical Trading Down 0.1 %
The company’s 50-day moving average is $16.17 and its 200 day moving average is $15.05. The company has a current ratio of 2.48, a quick ratio of 1.13 and a debt-to-equity ratio of 0.24. The firm has a market cap of $624.16 million, a PE ratio of -5.13 and a beta of 1.05.
Orthofix Medical (NASDAQ:OFIX – Get Free Report) last issued its earnings results on Tuesday, August 6th. The medical device company reported ($0.88) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.58). The business had revenue of $198.62 million during the quarter, compared to analyst estimates of $195.75 million. Orthofix Medical had a negative return on equity of 20.68% and a negative net margin of 15.61%. As a group, sell-side analysts predict that Orthofix Medical Inc. will post -2.13 EPS for the current year.
Institutional Trading of Orthofix Medical
About Orthofix Medical
Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.
Further Reading
- Five stocks we like better than Orthofix Medical
- CD Calculator: Certificate of Deposit Calculator
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- What are earnings reports?
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.